Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Norman E. Parker"'
1
Guidelines for point-of-care testing: haematology
Autor: David Guthrie, Mary Popek, Carol Briggs, Clare Stephens, Norman E. Parker, Ian J. Mackie, K. Hyde, Neil Porter
Publikováno v: British Journal of Haematology. 142:904-915
This guideline provides a framework for the arrangement of point-of-care testing (POCT) services, previously known as near patient testing (patient self-testing not covered). POCT is defined as any analytical test performed outside the laboratory. Pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c64c02abb95e4698109fbbd7d5216933
https://doi.org/10.1111/j.1365-2141.2008.07274.x
Zobrazit plný text záznamu
3
Hydroxyurea-induced pneumonitis in a patient with chronic idiopathic myelofibrosis after prolonged drug exposure
Autor: Norman E. Parker, Sarah J. Howling, David Brown, Chi C. Wong
Publikováno v: European Journal of Haematology. 71:388-390
We describe a 63-yr-old patient diagnosed with chronic idiopathic myelofibrosis whose disease was treated with hydroxyurea for 2 yr. He developed respiratory symptoms that were extensively investigated including lung biopsy. Clinical, radiological an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b0b8a9d30391d5243504a3fd4b89cb7a
https://doi.org/10.1034/j.1600-0609.2003.00123.x
Zobrazit plný text záznamu
5
Hydroxyurea-induced pneumonitis in a patient with chronic idiopathic myelofibrosis after prolonged drug exposure
Autor: Chi C, Wong, David, Brown, Sarah J, Howling, Norman E, Parker
Publikováno v: European journal of haematology. 71(5)
We describe a 63-yr-old patient diagnosed with chronic idiopathic myelofibrosis whose disease was treated with hydroxyurea for 2 yr. He developed respiratory symptoms that were extensively investigated including lung biopsy. Clinical, radiological an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::956866cb5b3c13dfa47b55cf41553696
https://pubmed.ncbi.nlm.nih.gov/14667203
Zobrazit plný text záznamu
7
Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome
Autor: James S. Wainscoat, Fiona J. Oliver, Stephan W. Morris, John Douglas Mcpherson, Carrie Fidler, Markus Kostrzewa, Lyndal Kearney, Rina J. Jaju, Norman E. Parker, Ulrich Müller, Jacqueline Boultwood
Publikováno v: Genes, chromosomes and cancer. 22(3)
The 5q- syndrome is a distinct type of myelodysplastic syndrome (MDS) characterised by refractory anaemia, morphological abnormalities of megakaryocytes, and del(5q) as the sole cytogenetic abnormality. In contrast to patients with therapy-related MD
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7eb720715af2ce08d9f8193ca78f124
http://ora.ox.ac.uk/objects/uuid:c45a049a-a824-40db-96da-18f09554df16
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje